Skip to main content

Journal article Published 2020

Scaffold hopping of the SYK inhibitor entospletinib leads to broader targeting of the BCR signalosome

European Journal of Medicinal Chemistry 204, 112636 (2020)

Cite this publication

JORDA, R., S. KRAJČOVIČOVÁ, P. KRÁLOVÁ, M. SOURAL, V. KRYŠTOF: Scaffold hopping of the SYK inhibitor entospletinib leads to broader targeting of the BCR signalosome. European Journal of Medicinal Chemistry. 2020, 204, 112636, ISSN: 0223-5234, PMID: 32731189.